In 2005, we will commercialize 5 kinds of vaccines and develop 4 different vaccines. In addition, this year we will also evaluate the protective efficacy of a bivalent vaccine composed of Iridovirus and Nodavirus antigens. The automatic system to vaccinapo fishes will be also established. The diagnostic technique weed on PCV2 based on real-time PCR assay will be developed. In avian, we will select the virus strains, which can be used in vaccine production in emergency. In 1996 and 1997, we will also develop 5 kinds of vaccines for commercialization.